首页 > 最新文献

Polish Journal of Surgery最新文献

英文 中文
Treatment of early-stage chronic venous disease – management standards for 2023 2023年早期慢性静脉疾病治疗管理标准
Q4 SURGERY Pub Date : 2023-03-09 DOI: 10.5604/01.3001.0016.2971
Zbigniew Krasiński, Beata Krasińska
Chronic venous disease (CVD) is one of the most prevalent diseases in the world. Most patients with early-stage CVD willeventually deteriorate, which will result in an increase in treatment costs, but most importantly, a decrease in quality of life.The advances made with regard to the knowledge of the natural history and pathophysiology of CVD as well as the results ofresearch on effects of different drugs depending on the severity of the disease suggest the likely cost-effectiveness of CVDpatients being treated at an early stage of the disease. Recommendations in this group of patients may include lifestylechanges, compression therapy and venoactive drugs (VADs). Combination of ruscus, hesperidin methyl chalcone, andvitamin C is a well-established VAD presenting with anti-inflammatory effects, reducing endothelial activation and leukocyteadhesion, increasing capillary resistance and integrity and improving venous tone and performance of the lymphatic vesselsthus leading to a reduction in CVD symptoms in patients and an improvement in quality of their lifes. This article is based onthe latest guidelines regarding the management of chronic venous disease.
慢性静脉疾病(CVD)是世界上最常见的疾病之一。大多数早期心血管疾病患者最终会恶化,这将导致治疗费用的增加,但最重要的是,生活质量下降。在心血管疾病的自然史和病理生理学知识方面取得的进展以及根据疾病严重程度对不同药物效果的研究结果表明,在疾病早期治疗心血管疾病患者可能具有成本效益。这组患者的建议包括改变生活方式、压迫治疗和静脉活性药物(VADs)。ruscus、橙皮苷甲基查尔酮和维生素C联合使用是一种成熟的VAD,具有抗炎作用,降低内皮细胞活化和白细胞粘附,增加毛细血管阻力和完整性,改善静脉张力和淋巴管的性能,从而减少CVD症状,改善患者的生活质量。这篇文章是基于最新的指导方针关于慢性静脉疾病的管理。
{"title":"Treatment of early-stage chronic venous disease – management standards for 2023","authors":"Zbigniew Krasiński, Beata Krasińska","doi":"10.5604/01.3001.0016.2971","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2971","url":null,"abstract":"Chronic venous disease (CVD) is one of the most prevalent diseases in the world. Most patients with early-stage CVD willeventually deteriorate, which will result in an increase in treatment costs, but most importantly, a decrease in quality of life.The advances made with regard to the knowledge of the natural history and pathophysiology of CVD as well as the results ofresearch on effects of different drugs depending on the severity of the disease suggest the likely cost-effectiveness of CVDpatients being treated at an early stage of the disease. Recommendations in this group of patients may include lifestylechanges, compression therapy and venoactive drugs (VADs). Combination of ruscus, hesperidin methyl chalcone, andvitamin C is a well-established VAD presenting with anti-inflammatory effects, reducing endothelial activation and leukocyteadhesion, increasing capillary resistance and integrity and improving venous tone and performance of the lymphatic vesselsthus leading to a reduction in CVD symptoms in patients and an improvement in quality of their lifes. This article is based onthe latest guidelines regarding the management of chronic venous disease.","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"280 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136179852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What are the surgical options for recurrent rectal prolapse - a retrospective single-center experience. 复发性直肠脱垂的手术选择-回顾性单中心经验。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2727
Tomasz Kościński, Krzysztof Szmyt

Objectives: Most authors highlight the absence of international guidelines in the treatment of recurrent rectal prolapse (RRP), even among coloproctologists. However, it is clearly indicated that Delormes or Thierschs surgeries are reserved for older and fragile patients, so on the other hand, transabdominal surgeries are dedicated to generally fitter patients. The aim of the study is evaluation of surgical treatment effects for recurrent rectal prolapse (RRP)Methods: The study group comprised of 20 female and 2 male patients aged from 37 to 92 years (subjected to treatment last 20 years). Initial treatment consisted of abdominal mesh rectopexy (n=4), perineal sigmorectal resection (n=9), Delormes technique (n=3), Thierschs anal banding (n=3), colpoperineoplasty (n=2), anterior sigmorectal resection (n=1). The relapses occured between 2 to 30 months.

Results: Reoperations consisted of abdominal without (n=8) or with resection rectopexy (n=3), perineal sigmorectal resection (n=5), Delormes technique (n=1), total pelvic floor repair (n=4), perineoplasty (n=1). 11 patients (50%) were completely cured. 6 patients developed subsequent RRP. They were successfully reoperated (2 rectopexies, 2 perineocolporectopexies, 2 perineal sigmorectal resections).

Conclusions: Abdominal mesh rectopexy is the most effective method for RP and RRP treatment. Total pelvic floor repair may prevent RRP. Perineal rectosigmoid resection results of less permament effects of RRP repair.

目的:大多数作者强调缺乏治疗复发性直肠脱垂(RRP)的国际指南,即使在直肠科医生中也是如此。然而,明确指出Delormes或Thierschs手术是为年长者和身体虚弱的患者保留的,而另一方面,经腹手术是为一般较健康的患者提供的。本研究旨在评价复发性直肠脱垂(RRP)手术治疗的效果。方法:研究组为女性20例,男性2例,年龄37 ~ 92岁(治疗时间近20年)。初始治疗包括腹部网状直肠固定术(n=4),会阴sigmo直肠切除术(n=9), Delormes技术(n=3), Thierschs肛门捆扎术(n=3),阴道肿瘤成形术(n=2),前sigmo直肠切除术(n=1)。复发发生在2至30个月之间。结果:再手术包括腹部不切除(n=8)或合并切除直肠固定术(n=3)、会阴sigmo直肠切除术(n=5)、Delormes技术(n=1)、全盆底修复(n=4)、会阴成形术(n=1)。11例(50%)完全治愈。6例患者出现后续RRP。再次手术成功(2例直肠切除术,2例会阴直肠切除术,2例会阴直肠直肠切除术)。结论:腹壁补片固定术是治疗RP和RRP最有效的方法。全盆底修复可预防RRP。会阴乙状结肠直肠切除术的效果较RRP修复效果小。
{"title":"What are the surgical options for recurrent rectal prolapse - a retrospective single-center experience.","authors":"Tomasz Kościński,&nbsp;Krzysztof Szmyt","doi":"10.5604/01.3001.0016.2727","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2727","url":null,"abstract":"<p><strong>Objectives: </strong>Most authors highlight the absence of international guidelines in the treatment of recurrent rectal prolapse (RRP), even among coloproctologists. However, it is clearly indicated that Delormes or Thierschs surgeries are reserved for older and fragile patients, so on the other hand, transabdominal surgeries are dedicated to generally fitter patients. The aim of the study is evaluation of surgical treatment effects for recurrent rectal prolapse (RRP)Methods: The study group comprised of 20 female and 2 male patients aged from 37 to 92 years (subjected to treatment last 20 years). Initial treatment consisted of abdominal mesh rectopexy (n=4), perineal sigmorectal resection (n=9), Delormes technique (n=3), Thierschs anal banding (n=3), colpoperineoplasty (n=2), anterior sigmorectal resection (n=1). The relapses occured between 2 to 30 months.</p><p><strong>Results: </strong>Reoperations consisted of abdominal without (n=8) or with resection rectopexy (n=3), perineal sigmorectal resection (n=5), Delormes technique (n=1), total pelvic floor repair (n=4), perineoplasty (n=1). 11 patients (50%) were completely cured. 6 patients developed subsequent RRP. They were successfully reoperated (2 rectopexies, 2 perineocolporectopexies, 2 perineal sigmorectal resections).</p><p><strong>Conclusions: </strong>Abdominal mesh rectopexy is the most effective method for RP and RRP treatment. Total pelvic floor repair may prevent RRP. Perineal rectosigmoid resection results of less permament effects of RRP repair.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10760383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in restoring bowel continuity: An analysis of 91 patients undergoing a reversal procedure 恢复胃肠道紧张的挑战。91例接受重建手术患者的单中心分析。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2733
Maciej Borejsza-Wysocki, Adam Bobkiewicz, Witold Ledwosiński, Krzysztof Szmyt, Tomasz Banasiewicz, Łukasz Krokowicz

Introduction: The restoration of bowel continuity is associated with significant postoperative morbidity. Aim: The aim of the study was to report the outcomes of restoring intestinal continuity in a large patient cohort.Material and methods: A retrospective analysis was conducted on 91 patients with terminal stoma who were qualified for restoration of GI tract continuity between January 2015 and March 2020. The following demographic and clinical characteristics were analyzed: age, gender, BMI, comorbidities, indication for stoma creation, operative time, the need for blood replacement, the site and type of the anastomosis, and complication and mortality rates.Results: The study group was comprised of 40 women (44%) and 51 men (56%). The mean BMI was 26.8 ±4.9 kg/m2. Only 29.7% of the patients (n = 27) were at normal weight (BMI: 18.5–24.9) and only 11% (n = 10) did not suffer from any comorbidities. The most common indications for index surgery were complicated diverticulitis (37.4%) and colorectal cancer (21.9%). The stapled technique was used in the majority of patients (n = 79, 87%). The mean operative time was 191.7 ±71.4 min.Nine patients (9.9%) required blood replacement peri- or postoperatively, whereas 3 patients (3.3%) required intensive care unit admission. The overall surgical complication rate was 36.2% (n = 33) and the mortality rate was 1.1% (n = 1).Discussion: Restoration of bowel continuity is quite a demanding and complex procedure and thus should be performed by an experienced surgical team. In the majority of patients, the complication rate represents only minor complications. The morbidity and mortality rates are acceptable and comparable to other publications.

肠道连续性的恢复与术后显著的发病率相关。目的:该研究的目的是报告在一个大型患者队列中恢复肠道连续性的结果。材料与方法:回顾性分析2015年1月至2020年3月期间符合胃肠道连续性修复条件的91例末端造口患者。分析以下人口学和临床特征:年龄、性别、BMI、合并症、造口指征、手术时间、补血需求、吻合部位和类型、并发症和死亡率。结果:研究组由40名女性(44%)和51名男性(56%)组成。平均BMI为26.8±4.9 kg/m2。只有29.7% (n = 27)的患者体重正常(BMI: 18.5-24.9),只有11% (n = 10)的患者没有任何合并症。指数手术最常见的适应症是并发憩室炎(37.4%)和结直肠癌(21.9%)。大多数患者(n = 79,87%)采用了吻合器技术。平均手术时间为191.7±71.4 min, 9例(9.9%)患者需要围手术期或术后换血,3例(3.3%)患者需要入住重症监护病房。总体手术并发症发生率为36.2% (n = 33),死亡率为1.1% (n = 1)。讨论:恢复肠道连续性是一项要求相当高且复杂的手术,因此应由经验丰富的外科团队进行。在大多数患者中,并发症率仅代表轻微并发症。发病率和死亡率是可以接受的,与其他出版物相当。
{"title":"Challenges in restoring bowel continuity: An analysis of 91 patients undergoing a reversal procedure","authors":"Maciej Borejsza-Wysocki, Adam Bobkiewicz, Witold Ledwosiński, Krzysztof Szmyt, Tomasz Banasiewicz, Łukasz Krokowicz","doi":"10.5604/01.3001.0016.2733","DOIUrl":"10.5604/01.3001.0016.2733","url":null,"abstract":"<p><p>Introduction: The restoration of bowel continuity is associated with significant postoperative morbidity. \u0000\u0000Aim: The aim of the study was to report the outcomes of restoring intestinal continuity in a large patient cohort.\u0000\u0000Material and methods: A retrospective analysis was conducted on 91 patients with terminal stoma who were qualified \u0000for restoration of GI tract continuity between January 2015 and March 2020. The following demographic and clinical \u0000characteristics were analyzed: age, gender, BMI, comorbidities, indication for stoma creation, operative time, the need for \u0000blood replacement, the site and type of the anastomosis, and complication and mortality rates.\u0000\u0000Results: The study group was comprised of 40 women (44%) and 51 men (56%). The mean BMI was 26.8 ±4.9 kg/m2. \u0000Only 29.7% of the patients (n = 27) were at normal weight (BMI: 18.5–24.9) and only 11% (n = 10) did not suffer from any \u0000comorbidities. The most common indications for index surgery were complicated diverticulitis (37.4%) and colorectal cancer \u0000(21.9%). The stapled technique was used in the majority of patients (n = 79, 87%). The mean operative time was 191.7 ±71.4 min.\u0000Nine patients (9.9%) required blood replacement peri- or postoperatively, whereas 3 patients (3.3%) required intensive care \u0000unit admission. The overall surgical complication rate was 36.2% (n = 33) and the mortality rate was 1.1% (n = 1).\u0000\u0000Discussion: Restoration of bowel continuity is quite a demanding and complex procedure and thus should be performed by \u0000an experienced surgical team. In the majority of patients, the complication rate represents only minor complications. The \u0000morbidity and mortality rates are acceptable and comparable to other publications.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"39-45"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9327227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged thromboprophylaxis with rivaroxaban after bariatric interventions: single centre experience. 减肥干预后利伐沙班延长血栓预防:单中心经验。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2729
Volodymyr Tyselskyi, Yegor Tryliskyy, Vitaliy Poylin, Andrey Kebkalo

BackgroundVenous thromboembolism (VTE) is common after bariatric surgery and extended prophylaxis is generally recommended. Low molecular weight heparin is the most commonly used agent but requires patients to be trained to self-inject and is expensive. Rivaroxaban is an oral daily formulation approved for VTE prophylaxis after orthopedic surgery. Efficacy and safety of rivaroxaban has been confirmed in major gastrointestinal resections by several observational studies. We report a single centre experience of using rivaroxaban as an agent for VTE prophylaxis in bariatric surgery. MethodsWe performed prospective cohort study assessing safety and efficacy of rivaroxaban as a medication for VTE prophylaxis in patients undergoing bariatric surgery in a single centre in Kyiv, Ukraine. Patients undergoing major bariatric procedure received perioperative prophylaxis of VTE with subcutaneous low molecular weight heparin and then were switched to rivaroxaban for total of 30 days starting on the 4th postoperative day. Thromboprophylaxis was performed in accordance with the VTE risks derived from the Caprini score. On the 3rd, 30th, 60th day after the operation, the patients underwent ultrasound examination of the portal vein, as well as the veins of the lower extremities. Telephone interviews were conducted 30 and 60 days after the surgery to evaluate the presence of complaints which may be characteristic for VTE as well as to assess compliance with the regimen and to assess patient satisfaction. Outcomes studies were incidence of VTE and adverse events related to rivaroxaban administration.Results110 patients were included in the study from July 2019 to May 2021. The average age of the patients was 43.6 years, the average preoperative BMI was 55 (35 to 75). One hundred and seven patients (97.3%) underwent laparoscopic intervention while three patients (2.7%) underwent laparotomy. Eighty-four patients underwent sleeve gastrectomy and twenty-six patients underwent other procedures, including bypass surgery. Average calculated risk of thromboembolic event was 5-6% based on Caprine index. All patients were treated with extended prophylaxis with rivaroxaban. The average follow-up period for patients was 6 months. There were no clinical or radiological evidence of thromboembolic complications in the study cohort. Overall complication rate was 7.2%, however, only one patient (0.9%) developed subcutaneous hematoma associated with rivaroxaban not requiring intervention. ConclusionExtended postoperative prophylaxis with rivaroxaban is safe and effective in preventing thromboembolic complications in patients undergoing bariatric surgery. It is preferred by patients and further studies should be considered to further evaluate its use in bariatric surgery.

背景:静脉血栓栓塞(VTE)在减肥手术后很常见,一般推荐延长预防措施。低分子量肝素是最常用的药物,但需要训练患者自我注射,而且价格昂贵。利伐沙班是一种被批准用于骨科手术后静脉血栓栓塞预防的每日口服制剂。利伐沙班的有效性和安全性已被几项观察性研究证实。我们报告了在减肥手术中使用利伐沙班作为静脉血栓栓塞预防剂的单中心经验。方法:我们在乌克兰基辅的一个单一中心进行了前瞻性队列研究,评估利伐沙班作为预防减肥手术患者静脉血栓栓塞的药物的安全性和有效性。接受重大减肥手术的患者围手术期采用皮下低分子肝素预防静脉血栓栓塞,然后从术后第4天开始改用利伐沙班治疗,共30天。血栓预防是根据capriti评分得出的静脉血栓栓塞风险进行的。术后第3天、第30天、第60天行门静脉及下肢静脉超声检查。手术后30天和60天进行电话访谈,以评估静脉血栓栓塞的特征,以及评估治疗方案的依从性和评估患者满意度。结果研究是与利伐沙班相关的静脉血栓栓塞发生率和不良事件。结果2019年7月至2021年5月,110例患者被纳入研究。患者平均年龄43.6岁,术前平均BMI为55(35 ~ 75)。107例(97.3%)患者行腹腔镜干预,3例(2.7%)患者行剖腹手术。84名患者接受了袖胃切除术,26名患者接受了其他手术,包括搭桥手术。基于Caprine指数计算的血栓栓塞事件平均风险为5-6%。所有患者均接受利伐沙班延长预防治疗。患者平均随访6个月。在研究队列中没有临床或放射学证据表明血栓栓塞并发症。然而,总并发症发生率为7.2%,只有1例患者(0.9%)发生与利伐沙班相关的皮下血肿,无需干预。结论延长利伐沙班预防减肥手术患者术后血栓栓塞并发症安全有效。它是患者的首选,应该考虑进一步的研究来进一步评估其在减肥手术中的应用。
{"title":"Prolonged thromboprophylaxis with rivaroxaban after bariatric interventions: single centre experience.","authors":"Volodymyr Tyselskyi,&nbsp;Yegor Tryliskyy,&nbsp;Vitaliy Poylin,&nbsp;Andrey Kebkalo","doi":"10.5604/01.3001.0016.2729","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2729","url":null,"abstract":"<p><p>BackgroundVenous thromboembolism (VTE) is common after bariatric surgery and extended prophylaxis is generally recommended. Low molecular weight heparin is the most commonly used agent but requires patients to be trained to self-inject and is expensive. Rivaroxaban is an oral daily formulation approved for VTE prophylaxis after orthopedic surgery. Efficacy and safety of rivaroxaban has been confirmed in major gastrointestinal resections by several observational studies. We report a single centre experience of using rivaroxaban as an agent for VTE prophylaxis in bariatric surgery. MethodsWe performed prospective cohort study assessing safety and efficacy of rivaroxaban as a medication for VTE prophylaxis in patients undergoing bariatric surgery in a single centre in Kyiv, Ukraine. Patients undergoing major bariatric procedure received perioperative prophylaxis of VTE with subcutaneous low molecular weight heparin and then were switched to rivaroxaban for total of 30 days starting on the 4th postoperative day. Thromboprophylaxis was performed in accordance with the VTE risks derived from the Caprini score. On the 3rd, 30th, 60th day after the operation, the patients underwent ultrasound examination of the portal vein, as well as the veins of the lower extremities. Telephone interviews were conducted 30 and 60 days after the surgery to evaluate the presence of complaints which may be characteristic for VTE as well as to assess compliance with the regimen and to assess patient satisfaction. Outcomes studies were incidence of VTE and adverse events related to rivaroxaban administration.Results110 patients were included in the study from July 2019 to May 2021. The average age of the patients was 43.6 years, the average preoperative BMI was 55 (35 to 75). One hundred and seven patients (97.3%) underwent laparoscopic intervention while three patients (2.7%) underwent laparotomy. Eighty-four patients underwent sleeve gastrectomy and twenty-six patients underwent other procedures, including bypass surgery. Average calculated risk of thromboembolic event was 5-6% based on Caprine index. All patients were treated with extended prophylaxis with rivaroxaban. The average follow-up period for patients was 6 months. There were no clinical or radiological evidence of thromboembolic complications in the study cohort. Overall complication rate was 7.2%, however, only one patient (0.9%) developed subcutaneous hematoma associated with rivaroxaban not requiring intervention. ConclusionExtended postoperative prophylaxis with rivaroxaban is safe and effective in preventing thromboembolic complications in patients undergoing bariatric surgery. It is preferred by patients and further studies should be considered to further evaluate its use in bariatric surgery.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10764896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recommendations for modern perioperative care for elective surgery: consensus of panel of exerts. 择期手术的现代围手术期护理建议:专家小组的共识。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2732
Stanislaw Klek, Justyna Rymarowicz, Jacek Sobocki, Tomasz Banasiewicz, Michał Pędziwiatr, Adam Dziki, Marek Jackowski, Michał Jankowski, Dariusz Kawecki, Wojciech Kielan, Aleksander Konturek, Kryspin Mitura, Dawid Murawa, Zbigniew Lorenc, Przemysław Matras, Piotr Myśliwiec, Piotr Richter, Maciej Słodkowski, Janusz Strzelczyk, Antoni Szczepanik, Marek Szczepkowski, Mirosław Szura, Wiesław Tarnowski, Maciej Śmietański, Krzysztof Zieniewicz, Grzegorz Wallner

Introduction: Correct surgical technique and perioperative care are two factors that can reduce the number of complications, improve treatment outcomes and shorten the length of hospital stay. The introduction of enhanced recovery protocols has changed the approach to patient care in some centers. However, there are significant differences among centers, and in some the standard of care has remained unchanged.

Aim: the goal of the panel was to develop recommendations for modern perioperative care in accordance with current medical knowledge in order to reduce the number of complications associated with surgical treatment. An additional goal was to optimize and standardize perioperative care among Polish centers.

Materials and methods: the development of these recommendations was based on a review of the available literature from the PubMed, Medline and Cochrane Library databases from January 1, 1985 to March 31, 2022, with particular emphasis on systematic reviews and clinical recommendations of recognized scientific societies. Recommendations were formulated in a directive form and were assessed using the Delphi method.

Results and conclusions: 34 recommendations for perioperative care were presented. They cover aspects of pre-, intra- and post-operative care. Implementation of the presented rules allows to improve the results of surgical treatment.

前言:正确的手术技术和围手术期护理是减少并发症发生、改善治疗效果、缩短住院时间的两个重要因素。增强康复方案的引入改变了一些中心的病人护理方法。然而,各中心之间存在显著差异,有些中心的护理标准保持不变。目的:小组的目标是根据当前的医学知识制定现代围手术期护理建议,以减少与手术治疗相关的并发症的数量。另一个目标是优化和标准化波兰中心的围手术期护理。材料和方法:这些建议的制定是基于对1985年1月1日至2022年3月31日期间PubMed、Medline和Cochrane图书馆数据库中可用文献的综述,特别强调系统综述和公认科学协会的临床建议。建议以指示形式制定,并使用德尔菲法进行评估。结果与结论:提出34项围手术期护理建议。它们涵盖了术前、术中和术后护理的各个方面。本规则的实施可以提高手术治疗的效果。
{"title":"Recommendations for modern perioperative care for elective surgery: consensus of panel of exerts.","authors":"Stanislaw Klek,&nbsp;Justyna Rymarowicz,&nbsp;Jacek Sobocki,&nbsp;Tomasz Banasiewicz,&nbsp;Michał Pędziwiatr,&nbsp;Adam Dziki,&nbsp;Marek Jackowski,&nbsp;Michał Jankowski,&nbsp;Dariusz Kawecki,&nbsp;Wojciech Kielan,&nbsp;Aleksander Konturek,&nbsp;Kryspin Mitura,&nbsp;Dawid Murawa,&nbsp;Zbigniew Lorenc,&nbsp;Przemysław Matras,&nbsp;Piotr Myśliwiec,&nbsp;Piotr Richter,&nbsp;Maciej Słodkowski,&nbsp;Janusz Strzelczyk,&nbsp;Antoni Szczepanik,&nbsp;Marek Szczepkowski,&nbsp;Mirosław Szura,&nbsp;Wiesław Tarnowski,&nbsp;Maciej Śmietański,&nbsp;Krzysztof Zieniewicz,&nbsp;Grzegorz Wallner","doi":"10.5604/01.3001.0016.2732","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2732","url":null,"abstract":"<p><strong>Introduction: </strong>Correct surgical technique and perioperative care are two factors that can reduce the number of complications, improve treatment outcomes and shorten the length of hospital stay. The introduction of enhanced recovery protocols has changed the approach to patient care in some centers. However, there are significant differences among centers, and in some the standard of care has remained unchanged.</p><p><strong>Aim: </strong>the goal of the panel was to develop recommendations for modern perioperative care in accordance with current medical knowledge in order to reduce the number of complications associated with surgical treatment. An additional goal was to optimize and standardize perioperative care among Polish centers.</p><p><strong>Materials and methods: </strong>the development of these recommendations was based on a review of the available literature from the PubMed, Medline and Cochrane Library databases from January 1, 1985 to March 31, 2022, with particular emphasis on systematic reviews and clinical recommendations of recognized scientific societies. Recommendations were formulated in a directive form and were assessed using the Delphi method.</p><p><strong>Results and conclusions: </strong>34 recommendations for perioperative care were presented. They cover aspects of pre-, intra- and post-operative care. Implementation of the presented rules allows to improve the results of surgical treatment.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10764898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The preventive effect of omega-3 fish oil on peritoneal adhesion formation. omega-3鱼油对腹膜粘连形成的预防作用。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2730
Kerem Karaman, Hüseyin Çakıroğlu, Fatıma Betül Nogay, Mehmet Ramazan Şekeroğlu, Fahri Yilmaz

Introduction: Postoperative peritoneal adhesions formed after abdominal surgery still continue to exist as an unresolved health problem.

Aim: The aim of the present study is to examine whether omega -3 fish oil has a preventive effect on postoperative peritoneal adhesions.

Methods: Twenty-one female Wistar-Albino rats were separated into 3 groups (sham, control, and experimental group), each consisting of 7 rats. In sham group, only laparotomy was performed. Both in control and experimental group rats; the right parietal peritoneum and cecum were traumatized to form petechiae. Following this procedure, unlike the control group, the abdomen was irrigated with omega-3 fish oil in the experimental group. Rats were re-explored on the 14th postoperative day and adhesions were scored. Tissue samples and blood samples were taken for histopathological and biochemical analysis.

Results: None of the omega-3 fish oil given rats developed macroscopically postoperative peritoneal adhesion (P=0.005). Omega-3 fish oil formed an anti-adhesive lipid barrier on injured tissue surfaces. Microscopic evaluation revealed diffuse inflammation with excessive connective tissue and fibroblastic activity in control group rats while foreign body reactions were common in omega-3 given rats. The mean amount of hydroxyproline in samples from injured tissues was significantly lower in omega-3 given rats than in control rats. (P=0.004).

Conclusion: Intraperitoneal application of omega-3 fish oil prevents postoperative peritoneal adhesions by forming an anti-adhesive lipid barrier on injured tissue surfaces. However, further studies are needed to determine whether this adipose layer is permanent or will be resorbed over time.

腹膜术后粘连作为一个未解决的健康问题仍然存在。目的:探讨omega -3鱼油对术后腹膜粘连的预防作用。方法:将21只雌性Wistar-Albino大鼠分为3组(假手术组、对照组、实验组),每组7只。假手术组仅开腹手术。对照组和实验组大鼠;右腹膜顶骨和盲肠损伤形成瘀点。在此过程中,与对照组不同的是,实验组用omega-3鱼油冲洗腹部。术后第14天再次探查大鼠并对粘连进行评分。取组织标本和血液标本进行组织病理学和生化分析。结果:omega-3鱼油给药大鼠术后未出现腹腔粘连(P=0.005)。欧米茄-3鱼油在受伤组织表面形成了抗粘连的脂质屏障。显微镜检查显示,对照组大鼠出现弥漫性炎症,结缔组织和成纤维细胞活动过度,而给予omega-3的大鼠出现异物反应。服用omega-3的大鼠损伤组织样本中羟基脯氨酸的平均含量明显低于对照组大鼠。(P = 0.004)。结论:腹膜内应用omega-3鱼油通过在损伤组织表面形成抗粘连的脂质屏障来防止术后腹膜粘连。然而,需要进一步的研究来确定这种脂肪层是永久性的还是会随着时间的推移被吸收。
{"title":"The preventive effect of omega-3 fish oil on peritoneal adhesion formation.","authors":"Kerem Karaman,&nbsp;Hüseyin Çakıroğlu,&nbsp;Fatıma Betül Nogay,&nbsp;Mehmet Ramazan Şekeroğlu,&nbsp;Fahri Yilmaz","doi":"10.5604/01.3001.0016.2730","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2730","url":null,"abstract":"<p><strong>Introduction: </strong>Postoperative peritoneal adhesions formed after abdominal surgery still continue to exist as an unresolved health problem.</p><p><strong>Aim: </strong>The aim of the present study is to examine whether omega -3 fish oil has a preventive effect on postoperative peritoneal adhesions.</p><p><strong>Methods: </strong>Twenty-one female Wistar-Albino rats were separated into 3 groups (sham, control, and experimental group), each consisting of 7 rats. In sham group, only laparotomy was performed. Both in control and experimental group rats; the right parietal peritoneum and cecum were traumatized to form petechiae. Following this procedure, unlike the control group, the abdomen was irrigated with omega-3 fish oil in the experimental group. Rats were re-explored on the 14th postoperative day and adhesions were scored. Tissue samples and blood samples were taken for histopathological and biochemical analysis.</p><p><strong>Results: </strong>None of the omega-3 fish oil given rats developed macroscopically postoperative peritoneal adhesion (P=0.005). Omega-3 fish oil formed an anti-adhesive lipid barrier on injured tissue surfaces. Microscopic evaluation revealed diffuse inflammation with excessive connective tissue and fibroblastic activity in control group rats while foreign body reactions were common in omega-3 given rats. The mean amount of hydroxyproline in samples from injured tissues was significantly lower in omega-3 given rats than in control rats. (P=0.004).</p><p><strong>Conclusion: </strong>Intraperitoneal application of omega-3 fish oil prevents postoperative peritoneal adhesions by forming an anti-adhesive lipid barrier on injured tissue surfaces. However, further studies are needed to determine whether this adipose layer is permanent or will be resorbed over time.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10753560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Systematic review and meta-analysis comparing ventral hernia repair using minimally-invasive extended totally extraperitoneal repair versus intraperitoneal onlay mesh repair. 系统回顾和荟萃分析比较采用微创扩展全腹膜外修补术和腹膜内补片修补术的腹疝修补术。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2728
Yegor Tryliskyy, Volodymyr Tyselskyi, Andrii Kebkalo, Nikita Ponomarov

Background: This systematic review and meta-analysis analysed was set up to compare totally extraperitoneal mesh repair (TEP) and intraperitoneal onlay mesh placement (IPOM) in patients undergoing minimally invasive ventral hernia mesh surgery (MIS-VHMS).

Methods: A systematic literature searches of three major databases were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to identify studies that compared two techniques of MIS-VHMS: TEP and IPOM. Primary outcome of interest was major complications post-operatively, defined as a composite outcome of surgical-site occurrences requiring procedural intervention (SSOPI), readmission to hospital, recurrence, reoperation or death. Secondary outcomes were intraoperative complications, duration of surgery, surgical site occurrence (SSO), SSOPI, postoperative ileus, post-operative pain. The risk of bias was assessed using Cohranes Risk of Bias tool 2 for randomized controlled trials (RCTs) and Newcastle-Ottawa score for observational studies (OSs).

Results: Five OSs and two RCTs al including total number of 553 patients were included. There was no difference in primary outcome (RD 0.00 [-0.05, 0.06], p=0.95), incidence of postoperative ileus. Operative time was longer in TEP (MD 40.10 [27.28, 52.91], p<0.01). TEP was found to be associated with less postoperative pain at 24h and 7days after surgery.

Conclusions: Both TEP and IPOM were detected to have equal safety profile and do not differ in SSO or SSOPI rates, incidence of postoperative ileus. TEP has longer operative time but provides better early postoperative pain outcomes. Further high-quality studies with long follow up evaluating recurrence and patient reported outcomes are needed. Comparison of other transabdominal and extraperitoneal MIS-VHMS techniques is another direction of future research. PROSPERO registration: CRD4202121099.

背景:本系统综述和荟萃分析旨在比较微创腹疝补片手术(MIS-VHMS)患者的全腹膜外补片修复(TEP)和腹腔内补片放置(IPOM)。方法:根据系统评价和荟萃分析首选报告项目(PRISMA)指南对三个主要数据库进行系统文献检索,以确定比较MIS-VHMS两种技术的研究:TEP和IPOM。主要结局是术后主要并发症,定义为手术部位发生需要手术干预(SSOPI)、再入院、复发、再手术或死亡的复合结局。次要结局为术中并发症、手术时间、手术部位发生(SSO)、SSOPI、术后肠梗阻、术后疼痛。对随机对照试验(rct)使用Cohranes偏倚风险评估工具2,对观察性研究(OSs)使用Newcastle-Ottawa评分评估偏倚风险。结果:共纳入5例os和2例rct,共553例患者。两组的主要转归(RD = 0.00 [-0.05, 0.06], p=0.95)、术后肠梗阻发生率无差异。TEP的手术时间更长(MD 40.10 [27.28, 52.91], p<0.01)。在术后24小时和7天,TEP与术后疼痛减轻有关。结论:TEP和IPOM均具有相同的安全性,并且在SSO或SSOPI发生率,术后肠梗阻发生率方面没有差异。TEP手术时间较长,但术后早期疼痛效果较好。需要进一步高质量的长期随访研究来评估复发和患者报告的结果。其他经腹和腹膜外MIS-VHMS技术的比较是未来研究的另一个方向。普洛斯彼罗注册:CRD4202121099。
{"title":"Systematic review and meta-analysis comparing ventral hernia repair using minimally-invasive extended totally extraperitoneal repair versus intraperitoneal onlay mesh repair.","authors":"Yegor Tryliskyy,&nbsp;Volodymyr Tyselskyi,&nbsp;Andrii Kebkalo,&nbsp;Nikita Ponomarov","doi":"10.5604/01.3001.0016.2728","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2728","url":null,"abstract":"<p><strong>Background: </strong>This systematic review and meta-analysis analysed was set up to compare totally extraperitoneal mesh repair (TEP) and intraperitoneal onlay mesh placement (IPOM) in patients undergoing minimally invasive ventral hernia mesh surgery (MIS-VHMS).</p><p><strong>Methods: </strong>A systematic literature searches of three major databases were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to identify studies that compared two techniques of MIS-VHMS: TEP and IPOM. Primary outcome of interest was major complications post-operatively, defined as a composite outcome of surgical-site occurrences requiring procedural intervention (SSOPI), readmission to hospital, recurrence, reoperation or death. Secondary outcomes were intraoperative complications, duration of surgery, surgical site occurrence (SSO), SSOPI, postoperative ileus, post-operative pain. The risk of bias was assessed using Cohranes Risk of Bias tool 2 for randomized controlled trials (RCTs) and Newcastle-Ottawa score for observational studies (OSs).</p><p><strong>Results: </strong>Five OSs and two RCTs al including total number of 553 patients were included. There was no difference in primary outcome (RD 0.00 [-0.05, 0.06], p=0.95), incidence of postoperative ileus. Operative time was longer in TEP (MD 40.10 [27.28, 52.91], p&lt;0.01). TEP was found to be associated with less postoperative pain at 24h and 7days after surgery.</p><p><strong>Conclusions: </strong>Both TEP and IPOM were detected to have equal safety profile and do not differ in SSO or SSOPI rates, incidence of postoperative ileus. TEP has longer operative time but provides better early postoperative pain outcomes. Further high-quality studies with long follow up evaluating recurrence and patient reported outcomes are needed. Comparison of other transabdominal and extraperitoneal MIS-VHMS techniques is another direction of future research. PROSPERO registration: CRD4202121099.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10753561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stoma close to the abdominal wound: a real technical problem. A description of a novel care strategy. 靠近腹部伤口的气孔是一个真正的技术问题。一种新型护理策略的描述。
IF 0.6 Q4 SURGERY Pub Date : 2023-02-17 DOI: 10.5604/01.3001.0016.2731
Maciej Borejsza-Wysocki, Adam Bobkiewicz, Witold Ledwosiński, Krzysztof Szmyt, Tomasz Banasiewicz, Łukasz Krokowicz

IntroductionIn some clinical scenarios, stoma site may be located close to the abdominal wound edge impeding optimal wound management and stoma care. We present a novel strategy of utility NPWT for management of simultaneous abdominal wound healing with stoma presence. Material and methodsRetrospective analysis of seventeen patients treated with a novel wound care strategy was conducted. Application of NPWT within wound bed, around stoma site and skin between allows for: 1) separating wound from stoma site, 2) maintaining the optimal environment for wound healing, 3) protecting peristomal skin and 4) facilitating application of ostomy appliances.ResultsThe study group comprised of twelve female (70,6 %) and five male (29,4%) with the mean age of 49.1 18.4 years The most common underlying pathology was Crohn s disease (n-5; 29,4%). Since NPWT was implemented, patients had undergone from 1 to 13 surgeries. Thirteen patients (76,5%) required intensive care unit admission. The mean time of hospital stay was 65,3 28,6 days (range: 36 134). The mean session of NPWT was 10.8 5.2 (range: 5 - 24) per patient. The range of the level of negative pressure was from -80 to 125 mmHg. In all patients, progress in wound healing was achieved resulting in granulation tissue formation, minimizing wound retraction and thus reduction of the wound area. As a result of NPWT, wound was granulated entirely, tertiary intension closure were achieved or patients were qualified for reconstructive surgery.DiscussionNPWT is safe and useful therapy for complicated abdominal wounds with the presence of stoma close to wounds edges. A novel care strategy allows for simultaneous technical opportunity to separate stoma from wound bed and facilitate wound healing.

在一些临床情况下,造口位置可能靠近腹部伤口边缘,阻碍了最佳的伤口处理和造口护理。我们提出了一种新的实用NPWT策略,用于管理同时腹部伤口愈合与造口存在。材料与方法对17例采用新型创面护理方法治疗的患者进行回顾性分析。NPWT应用于伤口床内、造口部位周围和创口之间的皮肤,可以实现:1)将创口与造口部位分离,2)维持创口愈合的最佳环境,3)保护口周皮肤,4)方便造口器具的应用。结果本组患者女性12例(70.06%),男性5例(29.4%),平均年龄49.1 ~ 18.4岁,以克罗恩病(n-5;29日,4%)。自实施NPWT以来,患者接受了1至13次手术。13例(76.5%)患者需要入住重症监护病房。平均住院时间分别为65,328,6 d(范围:36 134)。NPWT的平均时间为每名患者10.8 5.2(范围:5 - 24)。负压水平范围为-80 ~ 125 mmHg。在所有患者中,伤口愈合的进展导致肉芽组织的形成,最大限度地减少了伤口缩回,从而减少了伤口面积。由于NPWT,伤口完全颗粒化,三级强度闭合或患者有资格进行重建手术。讨论npwt是一种安全有效的治疗方法,用于复杂的腹部伤口,靠近伤口边缘存在气孔。一种新颖的护理策略允许同时有技术机会将造口与伤口床分离并促进伤口愈合。
{"title":"Stoma close to the abdominal wound: a real technical problem. A description of a novel care strategy.","authors":"Maciej Borejsza-Wysocki,&nbsp;Adam Bobkiewicz,&nbsp;Witold Ledwosiński,&nbsp;Krzysztof Szmyt,&nbsp;Tomasz Banasiewicz,&nbsp;Łukasz Krokowicz","doi":"10.5604/01.3001.0016.2731","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2731","url":null,"abstract":"<p><p>IntroductionIn some clinical scenarios, stoma site may be located close to the abdominal wound edge impeding optimal wound management and stoma care. We present a novel strategy of utility NPWT for management of simultaneous abdominal wound healing with stoma presence. Material and methodsRetrospective analysis of seventeen patients treated with a novel wound care strategy was conducted. Application of NPWT within wound bed, around stoma site and skin between allows for: 1) separating wound from stoma site, 2) maintaining the optimal environment for wound healing, 3) protecting peristomal skin and 4) facilitating application of ostomy appliances.ResultsThe study group comprised of twelve female (70,6 %) and five male (29,4%) with the mean age of 49.1 18.4 years The most common underlying pathology was Crohn s disease (n-5; 29,4%). Since NPWT was implemented, patients had undergone from 1 to 13 surgeries. Thirteen patients (76,5%) required intensive care unit admission. The mean time of hospital stay was 65,3 28,6 days (range: 36 134). The mean session of NPWT was 10.8 5.2 (range: 5 - 24) per patient. The range of the level of negative pressure was from -80 to 125 mmHg. In all patients, progress in wound healing was achieved resulting in granulation tissue formation, minimizing wound retraction and thus reduction of the wound area. As a result of NPWT, wound was granulated entirely, tertiary intension closure were achieved or patients were qualified for reconstructive surgery.DiscussionNPWT is safe and useful therapy for complicated abdominal wounds with the presence of stoma close to wounds edges. A novel care strategy allows for simultaneous technical opportunity to separate stoma from wound bed and facilitate wound healing.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10753563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of the monograph "Dietetics in oncological diseases". 《肿瘤性疾病中的营养学》专著综述。
IF 0.6 Q4 SURGERY Pub Date : 2023-01-26 DOI: 10.5604/01.3001.0016.2125
Bruno Szczygieł

The new monograph concerning the dietetics in oncological diseases was discussed.

讨论了关于肿瘤疾病营养学的新专著。
{"title":"Review of the monograph &quot;Dietetics in oncological diseases&quot.","authors":"Bruno Szczygieł","doi":"10.5604/01.3001.0016.2125","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2125","url":null,"abstract":"<p><p>The new monograph concerning the dietetics in oncological diseases was discussed.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9327228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of gastroschisis with the use of primary and staged closure based on the department's 20-year experience. 根据该科20年的经验,采用初级和分阶段封闭术治疗胃裂。
IF 0.6 Q4 SURGERY Pub Date : 2023-01-26 DOI: 10.5604/01.3001.0016.2122
Patrycja Sosnowska-Sienkiewicz, Ewa Bućko, Dominika Skinder, Przemysław Mańkowski

Abstractbackground: Gastroschisis is a common developmental anomaly of the abdominal front wall. The aim of surgical management is to restore the integrity of the abdominal wall and to insert the bowel into the abdominal cavity with the use of the primary or staged closure technique.The objective of this paper is to analyze our 20-year experience with surgical treatment of gastroschisis with primary and staged closure, to compare the postoperative course for the said techniques as well as to identify factors influencing the course and early results of treatment.

Methods: The research materials consist of a retrospective analysis of medical history of patients treated at the Pediatric Surgery Clinic in Poznan over 20 years period from 2000 to 2019. 59 patients were operated on: 30 girls and 29 boys.

Results: Surgical treatment was performed in all the cases. Primary closure was performed in 32% of the cases, whereas staged silo closure was performed in 68% of the cases. Postoperative analgosedation was used for 6 days on average after primary closures, and 13 days on average after staged closures. Generalized bacterial infection was present in 21% of patients treated with primary closures and 37% for staged closures. Infants treated with staged closure began enteral feeding considerably later (day 22) than those treated with primary closure (day 12).

Conclusions: It is not possible to indicate clearly which surgical technique is superior to the other based on the results obtained. When choosing the treatment method, the patient's clinical condition, associated anomalies, and the medical team's experience must be taken into consideration.

摘要背景:腹裂是一种常见的腹前壁发育异常。手术治疗的目的是恢复腹壁的完整性,并使用初级或分阶段闭合技术将肠插入腹腔。本文的目的是分析我们20年来手术治疗胃裂的初步和分期关闭的经验,比较上述技术的术后过程,并确定影响过程和早期治疗结果的因素。方法:回顾性分析2000 - 2019年20年间在波兹南儿科外科诊所就诊的患者的病史。手术59例:女孩30例,男孩29例。结果:所有病例均行手术治疗。32%的病例进行了初级封闭,68%的病例进行了分阶段封闭。初次闭合后平均使用6天,分期闭合后平均使用13天。21%的初次闭合患者出现全身性细菌感染,37%的分期闭合患者出现全身性细菌感染。分阶段封闭治疗的婴儿开始肠内喂养的时间(第22天)明显晚于初级封闭治疗的婴儿(第12天)。结论:根据所获得的结果,不可能明确指出哪种手术技术优于另一种手术技术。在选择治疗方法时,必须综合考虑患者的临床情况、相关的异常情况以及医疗团队的经验。
{"title":"Surgical management of gastroschisis with the use of primary and staged closure based on the department&apos;s 20-year experience.","authors":"Patrycja Sosnowska-Sienkiewicz,&nbsp;Ewa Bućko,&nbsp;Dominika Skinder,&nbsp;Przemysław Mańkowski","doi":"10.5604/01.3001.0016.2122","DOIUrl":"https://doi.org/10.5604/01.3001.0016.2122","url":null,"abstract":"<p><strong>Abstractbackground: </strong>Gastroschisis is a common developmental anomaly of the abdominal front wall. The aim of surgical management is to restore the integrity of the abdominal wall and to insert the bowel into the abdominal cavity with the use of the primary or staged closure technique.The objective of this paper is to analyze our 20-year experience with surgical treatment of gastroschisis with primary and staged closure, to compare the postoperative course for the said techniques as well as to identify factors influencing the course and early results of treatment.</p><p><strong>Methods: </strong>The research materials consist of a retrospective analysis of medical history of patients treated at the Pediatric Surgery Clinic in Poznan over 20 years period from 2000 to 2019. 59 patients were operated on: 30 girls and 29 boys.</p><p><strong>Results: </strong>Surgical treatment was performed in all the cases. Primary closure was performed in 32% of the cases, whereas staged silo closure was performed in 68% of the cases. Postoperative analgosedation was used for 6 days on average after primary closures, and 13 days on average after staged closures. Generalized bacterial infection was present in 21% of patients treated with primary closures and 37% for staged closures. Infants treated with staged closure began enteral feeding considerably later (day 22) than those treated with primary closure (day 12).</p><p><strong>Conclusions: </strong>It is not possible to indicate clearly which surgical technique is superior to the other based on the results obtained. When choosing the treatment method, the patient&apos;s clinical condition, associated anomalies, and the medical team&apos;s experience must be taken into consideration.</p>","PeriodicalId":43422,"journal":{"name":"Polish Journal of Surgery","volume":"95 4","pages":"1-5"},"PeriodicalIF":0.6,"publicationDate":"2023-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10753089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Polish Journal of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1